AntiCD20 monoclonal antibody-based radioimmunotherapy of relapsed chemoresistant aggressive post-transplantation B-lymphoproliferative disorder in heart-transplant recipient

Saved in:
Bibliographic Details
Published inThe lancet oncology Vol. 6; no. 8; pp. 629 - 631
Main Authors Jaeger, Gerald, Linkesch, Werner, Temmel, Werner, Neumeister, Peter
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.08.2005
Elsevier Limited
Subjects
Antibodies, Monoclonal - therapeutic use
Antigens, CD20 - immunology
Drug Resistance, Neoplasm
Heart Transplantation - adverse effects
Humans
Lymphoproliferative Disorders - drug therapy
Lymphoproliferative Disorders - etiology
Lymphoproliferative Disorders - immunology
Lymphoproliferative Disorders - radiotherapy
Male
Middle Aged
Radioimmunotherapy - methods
Treatment Outcome
Online AccessGet full text

Cover

More Information
Bibliography:ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ISSN:1470-2045
1474-5488
DOI:10.1016/S1470-2045(05)70286-2